IE38113B1 - Anti-smoking preparation - Google Patents

Anti-smoking preparation

Info

Publication number
IE38113B1
IE38113B1 IE1197/72A IE119772A IE38113B1 IE 38113 B1 IE38113 B1 IE 38113B1 IE 1197/72 A IE1197/72 A IE 1197/72A IE 119772 A IE119772 A IE 119772A IE 38113 B1 IE38113 B1 IE 38113B1
Authority
IE
Ireland
Prior art keywords
silver
preparations
smoking
compound
diamine complex
Prior art date
Application number
IE1197/72A
Other versions
IE38113L (en
Original Assignee
Woodcraft D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Woodcraft D filed Critical Woodcraft D
Publication of IE38113L publication Critical patent/IE38113L/en
Publication of IE38113B1 publication Critical patent/IE38113B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Confectionery (AREA)

Abstract

1336609 Anti-smoking preparations D C WOODCRAFT 26 Sept 1972 [23 Dec 1971] 59894/71 Heading A5B Orally acceptable anti-smoking preparations comprise a silver amine complex or a silver compound and an ammonium compound which in the dissolved state combines with silver to form silver diamine complex ions. Preferred compositions comprise a silver salt such as silver lactate or silver acetate and sufficient ammonium nitrate to convert all the silver to silver diamine complex, but silver salts plus thiosulphates may also be used. The preparations may be in conventional solid and liquid forms, e.g. a tablet, solution or aerosol preparation, and may optionally comprise a co-carboxylase. [GB1336609A]
IE1197/72A 1971-12-23 1972-09-04 Anti-smoking preparation IE38113B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5989471 1971-12-23

Publications (2)

Publication Number Publication Date
IE38113L IE38113L (en) 1973-06-23
IE38113B1 true IE38113B1 (en) 1978-01-04

Family

ID=10484601

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1197/72A IE38113B1 (en) 1971-12-23 1972-09-04 Anti-smoking preparation

Country Status (12)

Country Link
JP (1) JPS4885722A (en)
AU (1) AU5010472A (en)
BR (1) BR7208979D0 (en)
DE (1) DE2262497A1 (en)
DK (1) DK131892C (en)
FI (1) FI51049C (en)
GB (1) GB1336609A (en)
IE (1) IE38113B1 (en)
IL (1) IL40366A0 (en)
MT (1) MTP728B (en)
NL (1) NL7217411A (en)
ZA (1) ZA726026B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4747417A (en) * 1985-09-10 1988-05-31 Besco Laboratory Inc. Sprayable composition to prevent smoking
ATE283708T1 (en) * 1999-02-15 2004-12-15 Sumitomo Pharma TABLETS THAT DISSOLVE RAPIDLY IN THE ORAL AREA
GB2362571A (en) * 2000-03-14 2001-11-28 Azn Biotech Ltd Compositions for curbing smoking
JP3730522B2 (en) 2000-07-21 2006-01-05 太陽化学株式会社 Smoking craving suppression composition

Also Published As

Publication number Publication date
JPS4885722A (en) 1973-11-13
IE38113L (en) 1973-06-23
DK131892B (en) 1975-09-22
FI51049C (en) 1976-10-11
NL7217411A (en) 1973-06-26
MTP728B (en) 1973-02-15
DE2262497A1 (en) 1973-07-05
AU5010472A (en) 1974-06-20
FI51049B (en) 1976-06-30
ZA726026B (en) 1973-05-30
BR7208979D0 (en) 1973-09-20
DK131892C (en) 1976-02-16
GB1336609A (en) 1973-11-07
IL40366A0 (en) 1972-11-28

Similar Documents

Publication Publication Date Title
IE32758L (en) Propanolamine derivatives
CA973554A (en) 2,3,5,6-tetraaminopyridine and its acid salts and processes for its preparation
GB1270781A (en) Tableting medium
AU468994B2 (en) 2,3-DIHYDRO-OXOIMIDAZO [1,2-a] PYRIMIDINES, THEIR ACID ADDITION SALTS THEREOF AND PROCESSES FOR THEIR PREPARATION
IE38641L (en) Pyrazolodiazepine compounds
IE38113B1 (en) Anti-smoking preparation
IE35376L (en) Pyrimidine derivatives
CA936533A (en) 5-aryl-2,3-dihydro-2,2(or 3,3) dimethyl-5h-imidazo(2,1-a) isoindol-5-ols and 2(4,4(5,5) dimethyl-2-imidazolin-2-yl) bensophenone acid addition salts and processes for their preparation
GB1182815A (en) New Salts of N-Carbamyl-Glutamic Acid and of N-Carbamyl-Aspartic Acid.
IE38114L (en) Anti-smoking chewing gum preparation
GB1362845A (en) Benzyl alcohol derivatives
IE35507L (en) Preparations containing tetrahydrocarbazole¹derivatives
GB1202189A (en) Process for the preparation of 4-aminomethylcyclohexane-1-carboxylic acid
IE33581L (en) Compositions comprising l-dopa
CA1022564A (en) 3-aryl-2-halothiopropionic acid derivatives, their preparation and their use as herbicides
IE33519B1 (en) Novel benzyl-hydrazide derivatives and a process for the manufacture thereof and novel benzylidene-hydrazide derivatives useful in said process
ZA715813B (en) Improvements relating to 1,2,3,6-tetrahydro-4-pyridylmethyl-carbonic acid esters,as well as the acid addition salts and quaternary ammonium compounds thereof
IE34386B1 (en) Pharmaceutical compositions
IE32211B1 (en) Therapeutic compositions
GB1263206A (en) Complexes and salts of magnesium with orotic acid and amino acids
GB1349207A (en) Pharmaceutical compositions
GB1279392A (en) Sugar-free compositions
IE32746L (en) Pharmaceutical preparation
FI52422C (en) Concentrated aqueous solutions of the potassium salt of alpha- (2,4-dichlorophenoxy) propionic acid and the process for their preparation.
CA1018993A (en) Biocidal 3,5-dibromosalicylic acid salts